The Department of Health and Human Services June 1 announced that the next deadline for submitting data to inform the agency’s distribution of its supply of remdesivir is June 8 at 8 p.m. ET.

HHS is requesting the same data as last month’s remdesivir request – that is, the number of currently hospitalized COVID-19 patients, and of those hospitalized, the number requiring placement in intensive care units. Hospitals should again submit the data using the HHS TeleTracking web portal. Registered users of TeleTracking received an email yesterday announcing this next round of data collection.

See yesterday’s AHA Special Bulletin for more details.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…